Usman Baber to Thrombolytic Therapy
This is a "connection" page, showing publications Usman Baber has written about Thrombolytic Therapy.
Connection Strength
0.451
-
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):192-194.
Score: 0.155
-
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. Am Heart J. 2018 11; 205:63-69.
Score: 0.153
-
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017 Nov 15; 90(6):1016-1026.
Score: 0.142